Explore the Latest from Hematopoiesis

While the focus of hematology fellowship training has traditionally been on single-board pathways (e.g., hematology or pediatric hematology/oncology) versus the double-board pathway in adult training (hematology and medical oncology), there is growin...

What Is Transfusion Medicine? Transfusion medicine is a subspecialty that focuses on providing blood and its components to patients. However, since the 1600s, transfusion medicine has evolved significantly into the field we know today. From the first...

As a first-year hematology/oncology fellow watching a bulky lymph node melt away with chemotherapy, I realized that treating lymphoma was uniquely rewarding. Moments like these drew me toward lymphoma and ultimately led me to pursue an advanced lymph...

In our last article, we discussed how hematology-oncology (HO) fellowship applicants can thoughtfully approach the application process to seek out programs that best align with their career goals to “find their fit.” Here, we focus on the...

A 79-year-old female with past medical history of chronic lymphocytic leukemia (CLL), hypothyroidism, and hypertension presented to the hospital for hypercalcemia and a lytic lesion of the left distal femur. She initially presented to her outpatient...

Nothing quite matches the excitement of reaching the end of hematology and oncology training. It is a journey that spans many years: from the first days of undergraduate to the end of fellowship. This is a huge accomplishment! Throughout medical trai...

The hematology-oncology (HO) fellowship application process can feel overwhelming for prospective fellows. We hope to provide practical insights into key aspects of the application process to help navigate the path to fellowship. To help applicants f...

Background Pancytopenia has a broad differential in pediatrics,1,2 including infectious bone marrow suppression,3-5 bone marrow failure syndromes,6-8 and hematologic malignancies.9 While clinical features aid diagnostic evaluation, definitive diagnos...

Sickle cell disease (SCD) is a hemoglobinopathy that affects 500,000 newborns annually, the majority of whom live in sub-Saharan Africa.1,2 In Western Kenya, an estimated 20% to 25% of the population carries the sickle cell trait and approximately 1....

Global hematology is often framed as a future aspiration taking shape as infrastructure and workforce capacity mature. In Malawi, global hematology unfolds in crowded clinics, wards, and blood banks where sickle cell disease (SCD), cancer, and transf...